Trio Lifescience

Ahmedabad, India Founded: 2007 • Age: 19 yrs
Manufacturer of generic tablets, capsules, syrup, creams, and injectables

About Trio Lifescience

Trio Lifescience is a company based in Ahmedabad (India) founded in 2007. It operates as a Traditional Pharmaceuticals. The company has 14 employees. Trio Lifescience offers products and services including Trio Lifescience Platform.

Key Metrics
  • Annual Revenue
    ₹8.48 Cr

    FY 2024 · +11% YoY

  • Net Profit
    ₹12.4 Lakh

    FY 2024 · 1% margin

  • EBITDA
    ₹73.8 Lakh

    FY 2024 · 9% margin

  • Employee Count
    14

Products & Services of Trio Lifescience

Trio Lifescience offers a comprehensive portfolio of products and services, including Trio Lifescience Platform.

Trio Lifescience Platform
Healthcare

Manufacturer of generic tablets, capsules, syrup, creams, and injectables

Board of directors of Trio Lifescience Private Limited (Trio Lifescience)

Trio Lifescience Private Limited is the primary company behind Trio Lifescience. The board of Trio Lifescience Private Limited currently have 2 directors; the longest-serving is Amit Jayantkumar Vadhiya, appointed in 2007. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Amit Jayantkumar Vadhiya
DIN 01291457
Director20 Aug 200719 yrs 1 moTrio Lifescience Private Limited
Jayantkumar Nanjibhai Vadhiya
DIN 01403358
Director31 Mar 201511 yrs 6 moTrio Lifescience Private Limited

People of Trio Lifescience

1 people are tracked at Trio Lifescience (1 in leadership); the tracked headcount is 14.

NameRoleGroup
CEO & DirectorLeadership
Premium access

Complete people profiles for Trio Lifescience

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Trio Lifescience

Figures of Trio Lifescience Private Limited, the primary company behind Trio Lifescience, for FY 2024. Revenue was ₹8.48 Cr (+11% year on year). Net profit was ₹12.4 Lakh (1% margin). EBITDA was ₹73.8 Lakh (9% margin). Revenue has grown at a compounded annual rate of +19% over three years and +12% over five years.

  • ₹8.48 CrRevenue · FY 2024 · +11% YoY
  • ₹12.4 LakhNet profit · 1% margin
  • ₹73.8 LakhEBITDA · 9% margin
  • ₹11 LakhPaid-up capital
  • 14Employees (provident fund records)
  • +19%Revenue CAGR, 3 years
  • +12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Trio Lifescience Private Limited are on its company page.

Premium access

Detailed financial statements for Trio Lifescience

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Trio Lifescience

The website of Trio Lifescience (triolifescience.com) receives about 1.9K visits a month.

  • Monthly visits
    1.9K

    ▲ 40.4% vs previous month

Similar companies to Trio Lifescience

10 companies that operate in the same segment as Trio Lifescience (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Trio Lifescience

Trio Lifescience was founded in 2007.

Trio Lifescience is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Amit Vadhiya is the current CEO of Trio Lifescience.

Trio Lifescience has 14 employees.

The primary company behind Trio Lifescience, Trio Lifescience Private Limited, reported revenue of β‚Ή8.48 Cr for FY 2024, up 11% year on year.

Trio Lifescience operates with a Traditional Pharmaceuticals model, focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic tablets, capsules, syrup, creams, and injectables. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Trio Lifescience offers Trio Lifescience Platform.

Trio Lifescience operates through Trio Lifescience Private Limited.

The legal entities of Trio Lifescience currently have 2 directors, including Amit Jayantkumar Vadhiya, Jayantkumar Nanjibhai Vadhiya.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available